Chemotherapy-induced changes in cardiac capillary permeability measured by fluorescent multiple indicator dilution

Area of Science:

• Cardiovascular Research
• Pharmacology
• Toxicology

Background:

• Anthracyclines are potent chemotherapy agents known to cause severe, irreversible cardiac toxicity.
• Understanding the mechanisms of anthracycline cardiotoxicity is crucial for developing safer cancer treatments.
• Changes in cardiac capillary permeability may play a significant role in chemotherapy-induced heart damage.

Purpose of the Study:

• To investigate the effect of doxorubicin chemotherapy on cardiac capillary permeability in rats.
• To correlate changes in cardiac permeability with functional cardiac deficits.
• To evaluate the utility of a fluorescent multiple indicator dilution technique for assessing chemotherapy-induced cardiotoxicity.

Main Methods:

• Thirty-six rats were divided into control and doxorubicin treatment groups.
• Doxorubicin was administered intraperitoneally over 12 days.
• Cardiac function was assessed via echocardiography, and cardiac capillary permeability was measured using a Texas Red/sodium fluorescein multiple indicator dilution method in isolated perfused hearts.

Main Results:

• Doxorubicin-treated rats exhibited significantly higher cardiac capillary permeability-surface-area-products compared to controls (0.066 vs. 0.035 cm(3)/s).
• Chemotherapy led to significant declines in fractional shortening, left ventricular developed pressure, contractility, and relaxation.
• Increased cardiac capillary permeability correlated with impaired cardiac function.

Conclusions:

• In vivo chemotherapy treatment with doxorubicin alters cardiac capillary permeability.
• The fluorescent multiple indicator dilution technique can detect these permeability changes.
• This method offers valuable insights for evaluating the cardiotoxicity of novel chemotherapeutic agents.